The North America Magnetoencephalography Market would witness market growth of 4.6% CAGR during the forecast period (2022-2028).
Magnetoencephalography gives researchers a tool that is entirely noninvasive with which to investigate the human brain's real-time functioning under experimental conditions suited to the investigation of sensory and cognitive brain functions in addition to the disruptions that can occur in these functions.
When considering the potential role that MEG will play in the future of cognitive brain research, it is vital to keep in mind that MEG and EEG are the only noninvasive methods that can provide accurate temporal information about the patterns of brain activation that occur in response to the external environment. In addition, when comparing these two methods, MEG locates sources with a far higher degree of precision.
Although there is a possibility that MEG might be more "patient-friendly" than EEG because it does not involve the implantation of electrodes on the scalp, the much higher cost of MEG has mainly prevented its usage in everyday settings. Instead, MEG has been used primarily for one purpose: to pinpoint the origin of evoked potentials and localized epileptiform activity. This is often done to use the technique in epilepsy surgery.
As of 2014, there were approximately 6 million senior citizens living in Canada, making up about 15.6 percent of the country's total population. In Canada, the number of people aged 65 and older is expected to surpass 9.5 million by the year 2030, which is less than 20 years away. This age group has a significantly increased chance of developing neurological diseases. As a result of the increased prevalence of neurological illnesses throughout the region's countries, there will be an increased need for magnetoencephalography, which will support market growth.
The US market dominated the North America Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $88,192.6 Thousands by 2028. The Canada market is experiencing a CAGR of 6.9% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 6% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Magnetoencephalography Market is Predict to reach $350.1 Million by 2028, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
By Application
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
